Abstract
Objectives
To analyze multiple risk factors of necrotizing enterocolitis (NEC) and the outcome.
Methods
Hundred neonates with NEC were compared with 100 normal neonates matched for sex, gestation and weight. Their data including antenatal, natal, course of illness, hospital stay, progress and outcome were collected. Univariate analysis and logistic regression were used to analyze the risk factors.
Results
Mean age of onset of NEC was 2.35 ± 1.11 d. Stage I, II and III were noted in 48 %, 39 % and 13 % of cases respectively. Most common clinical features were abdominal distension (85 %) and feed intolerance (70 %). Important risk factors associated with NEC were sepsis, top feeding, perinatal asphyxia, respiratory distress and mechanical ventilation. Antenatal steroids and breast feeding had beneficial effect. No association was found with occurrence of NEC and cyanotic heart disease or administration of H2 blockers. Outcome in stage III was very poor.
Conclusions
Early identification of risk factors and appropriate intervention may reduce the incidence and improve the outcome in NEC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. 2006;368:1271–83.
Neu J, Mshvildadze M, Mai V. A roadmap for understanding and preventing necrotizing enterocolitis. Curr Gastroenterol Rep. 2008;10:450–7.
Patole SK. Prevention and treatment of necrotizing enterocolitis in preterm neonates. Early Hum Dev. 2007;83:635–42.
Walsh MC, Kliegman RM, Fanaroff AA. Necrotizing enterocolitis: A practitioner’s perspective. Pediatr Rev. 1988;9:219–26.
Updegrove K. Necrotizing enterocolitis: The evidence for use of human milk in prevention and treatment. J Hum Lact. 2004;20:335–9.
Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. 2006;368:1271–83.
Narang A, Rao R, Bhakoo ON. Neonatal necrotizing enterocolitis an epidemiological study. Indian Pediatr. 1993;30:1207–14.
Thomas C, Krishnan L. Neonatal necrotizing enterocolitis. Indian Pediatr. 1997;34:47–51.
Kliegman RM, Fanaroff AA. Neonatal necrotizing enterocolitis: A nine year experience. Am J Dis Child. 1981;135:603–7.
Krediet TG, van Lelyveld N, Vijlbrief DC, Brouwers HA, Kramer WL, Fleer A, et al. Microbiological factors associated with neonatal necrotizing enterocolitis: Protective effect of early antibiotic treatment. Acta Paediatr. 2003;92:1180–82.
de la Cochetiere MF, Piloquet H, des Robert C, Darmaun D, Galmiche JP, Roze JC. Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: The putative role of Clostridium. Pediatr Res. 2004;56:366–70.
Kamitsuka MD, Horton MK, Williams MA. The incidence of necrotising enterocolitis after introducing standardized feeding schedules for infants between 1250 and 2500 grams and less than 35 weeks of gestation. Pediatrics. 2000;105:379–84.
Guthrie SO, Gordon PV, Thomas V, Thorp JA, Peabody J, Clark RH. Necrotizing enterocolitis among neonates in the United States. J Perinatol. 2003;23:278–85.
Caplan MS, Amer M, Jilling T. The role of human milk in necrotizing enterocolitis. Adv Exp Med Biol. 2002;503:83–90.
Hanson LA. Human milk and host defence: Immediate and long-term effects. Acta Paediatr Suppl. 1999;88:42–6.
Nowicki PT, Nankervis CA. The role of the circulation in the pathogenesis of necrotizing enterocolitis. Clin Perinatol. 1994;21:219–34.
Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364:255–64.
Nowicki PT. Ischemia and necrotizing enterocolitis: Where, when, and how. Semin Pediatr Surg. 2005;14:152–8.
Schnabl KL, Van Aerde JE, Thomson AB, Clandinin MT. Necrotizing enterocolitis: A multifactorial disease with no cure. World J Gastroenterol. 2008;14:2142–61.
Yost CC. Neonatal necrotizing enterocolitis: Diagnosis, management, and pathogenesis. J Infus Nurs. 2005;28:130–4.
Guthrie SO, Gordon PV, Thomas V, Thorp JA, Peabody J, Clark RH. Necrotizing enterocolitis among neonates in the United States. J Perinatol. 2003;23:278–85.
Ward RM, Beachy JC. Neonatal complications following preterm birth. BJOG. 2003;110:S8–16.
Carter BM, Holditch-Davis D. Risk factors for necrotizing enterocolitis in preterm infants: How race, gender, and health status contribute. Adv Neonatal Care. 2008;8:285–90.
Dominguez KM, Moss RL. Necrotizing enterocolitis. Clin Perinatol. 2012;39:387–401.
Guillet R, Stoll BJ, Cotten CM, Gantz M, McDonald S, Poole WK, et al; National Institute of Child Health and Human Development Neonatal Research Network. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2006;117:e137–42.
Luig M, Lui K; NSW & ACT NICUS Group. Epidemiology of necrotizing enterocolitis— Part II: Risks and susceptibility of premature infants during the surfactant era: A regional study. J Paediatr Child Health. 2005;41:174–9.
Contributions
BG: Collected data and drafted the manuscript; BVB: Involved in the conception of the study and correction of the manuscript; BA, RJ, PP, PF and BS: Helped in data collection and reviewed the manuscript. BVB will act as guarantor for this paper.
Conflict of Interest
None.
Role of Funding Source
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gane, B., Bhat, B.V., Adhisivam, B. et al. Risk Factors and Outcome in Neonatal Necrotising Enterocolitis. Indian J Pediatr 81, 425–428 (2014). https://doi.org/10.1007/s12098-013-1311-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-013-1311-5